EBRO 2017

Trials of radiotherapy after mastectomy and axillary dissection

1133 pN1-3 women in trials with systemic therapy

RT: Significant benefit

Locoregional recurrence first

Any first recurrence Breast cancer mortality

11.7%

7.9%

Years since randomisation Years since randomisation

Years since randomisation

EBCTCG, Lancet 2014